Overview
What is Microbiome Therapeutic Innovation Group?
The Microbiome Therapeutic Innovation Group is a nonprofit organization situated in Washington D.C., specifically at 1001 Pennsylvania Avenue NW 1300N. Their primary objective is to advocate for the common business interests of microbiome therapeutics and microbiome-based product companies. They strive to promote their voice in the regulatory arena, working towards establishing clarification on matters such as clinical trial designs, endpoint selections, and evidential burdens. By utilizing collective power, they aim to enhance the regulatory, investment, and commercial environment for these types of products, ultimately improving their overall impact and accessibility.
Official website here: www.microbiometig.org
Is Microbiome Therapeutic Innovation Group legitimate?
Microbiome Therapeutic Innovation Group is a legitimate nonprofit organization registered as a 501(c)(6) entity. Microbiome Therapeutic Innovation Group submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.microbiometig.org
What is the mission statement of Microbiome Therapeutic Innovation Group?
The Microbiome Therapeutic Innovation Group's mission is to advocate for the collective interests of companies involved in microbiome therapeutics and microbiome-based product development. Their goal is to improve the regulatory, investment, and commercial environment for these sectors by seeking regulatory clarity on issues such as clinical trial designs, endpoint selections, and evidential burdens. The group utilizes its collective power to promote policies that can benefit the microbiome therapeutics and microbiome-based product industries. Their activities primarily involve lobbying on behalf of these companies to ensure their interests are represented and considered in relevant policies and decisions.
Official website here: www.microbiometig.org
Who is the CEO of Microbiome Therapeutic Innovation Group?
Tom Fagley is the Chairman of Microbiome Therapeutic Innovation Group.
Official website here: www.microbiometig.org
What is the revenue of Microbiome Therapeutic Innovation Group?
Microbiome Therapeutic Innovation Group's revenue in 2022 was $394,988.
Official website here: www.microbiometig.org
Who are the executives of Microbiome Therapeutic Innovation Group and what are their salaries?
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.microbiometig.org
Where can I find the form 990 for Microbiome Therapeutic Innovation Group?
Microbiome Therapeutic Innovation Group's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.microbiometig.org
Learn more at the official website: www.microbiometig.org
Mission Statement of Microbiome Therapeutic Innovation Group
The Microbiome Therapeutic Innovation Group, in its mission, serves as an advocate for the collective business interests of microbiome therapeutics and microbiome-based product companies. Its primary objective is to utilize its collective power to improve the regulatory, investment, and commercial environment for these sectors. The group aims to seek regulatory clarity on issues such as clinical trial designs, endpoint selections, and evidential burdens, thereby promoting the growth and development of the microbiome therapeutics and microbiome-based products industry. By doing so, the Microbiome Therapeutic Innovation Group strives to represent and promote the voice of these companies, providing valuable guidance and policies that can pave the way for their success.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Microbiome Therapeutic Innovation Group significantly influences the regulatory landscape for microbiome therapeutics and products. By representing and advocating for the common business interests of the industry, the organization works diligently to provide guidance and clarity on critical regulatory issues. This includes helping to shape clinical trial designs, endpoint selections, and evidential burdens, ensuring that companies can more effectively navigate the complex regulatory environment.
Their collaborative efforts enhance the investment and commercial climate for microbiome-based innovations, fostering an environment conducive to research and development. This not only supports the growth of the microbiome sector but also ultimately benefits patients and communities by facilitating the development of new therapeutic options. Through lobbying and advocacy, the group amplifies the industry's voice, pushing for policies that streamline processes and encourage innovation, thereby driving progress in the field of microbiome therapeutics.
This information is meant to be a general summary of Microbiome Therapeutic Innovation Group. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $8
- Gross Receipts: $394,988
Assets and Liabilities:
- Total Assets: $59,163
- Total Liabilities: $0
- Net Assets: $59,163
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2017
Phone
(202) 577-1370Principal Officer
Tom Fagley
Main Address
1001 PENNSYLVANIA AVE NW 1300N, WASHINGTON, DC, 20004
Website
www.microbiometig.orgNTEE Category
Code: S41 - Community improvement
If you are a representative of Microbiome Therapeutic Innovation Group and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.